Literature DB >> 8101040

Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.

C J Danpure1, P E Purdue, P Fryer, S Griffiths, J Allsop, M J Lumb, K M Guttridge, P R Jennings, J I Scheinman, S M Mauer.   

Abstract

Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disease caused by a deficiency of the liver-specific peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT). Three unrelated PH1 patients, who possess a novel complex phenotype, are described. At the enzymological level, this phenotype is characterized by a complete, or nearly complete, absence of AGT catalytic activity and reduced AGT immunoreactivity. Unlike normal individuals in whom the AGT is confined to the peroxisomal matrix, the immunoreactive AGT in these three patients was distributed approximately equally between the peroxisomes and mitochondria. The peroxisomal AGT appeared to be aggregated into amorphous core-like structures in which no other peroxisomal enzymes could be identified. Mutational analysis of the AGT gene showed that two of the three patients were compound heterozygotes for two previously unrecognized point mutations which caused Gly41-->Arg and Phe152-->Iso amino acid substitutions. The third patient was shown to be a compound heterozygote for the Gly41-->Arg mutation and a previously recognized Gly170-->Arg mutation. All three patients were homozygous for the Pro11-->Leu polymorphism that had been found previously with a high allelic frequency in normal populations. It is suggested that the Phe152-->Iso and Gly170-->Arg substitutions, which are only eighteen residues apart and located in the same highly conserved internal region of 58 amino acids, might be involved in the inhibition of peroxisomal targeting and/or import of AGT and, in combination with the Pro11-->Leu polymorphism, be responsible for its aberrant mitochondrial compartmentalization. On the other hand, the Gly41-->Arg substitution, either in combination with the Pro11-->Leu polymorphism or by itself, is predicted to be responsible for the intraperoxisomal aggregation of the AGT protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101040      PMCID: PMC1682352     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  Human hepatic peroxisomes with crystalloid cores associated with urate oxidase activity.

Authors:  L A De-Netto; P S Tappia; Z A Malik; A J Wood; V M Mann; C J Jones; K Burdett; J P Neoptolemos; M J Connock
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Localization of urate oxidase in the crystalline cores of rat liver peroxisomes by immunocytochemistry and immunoblotting.

Authors:  A Völkl; E Baumgart; H D Fahimi
Journal:  J Histochem Cytochem       Date:  1988-04       Impact factor: 2.479

5.  Isolation and characterization of an L-alanine: glyoxylate aminotransferase from human liver.

Authors:  J S Thompson; K E Richardson
Journal:  J Biol Chem       Date:  1967-08-25       Impact factor: 5.157

6.  Molecular evolution of alanine/glyoxylate aminotransferase 1 intracellular targeting. Analysis of the marmoset and rabbit genes.

Authors:  P E Purdue; M J Lumb; C J Danpure
Journal:  Eur J Biochem       Date:  1992-07-15

7.  A serine-to-phenylalanine substitution leads to loss of alanine:glyoxylate aminotransferase catalytic activity and immunoreactivity in a patient with primary hyperoxaluria type 1.

Authors:  Y Minatogawa; S Tone; J Allsop; P E Purdue; Y Takada; C J Danpur; R Kido
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

8.  A new micro-assay for human liver alanine: glyoxylate aminotransferase.

Authors:  J Allsop; P R Jennings; C J Danpure
Journal:  Clin Chim Acta       Date:  1987-12       Impact factor: 3.786

9.  Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation.

Authors:  P E Purdue; J Allsop; G Isaya; L E Rosenberg; C J Danpure
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

10.  Human hepatic microbodies with crystalloid cores.

Authors:  L Biempica
Journal:  J Cell Biol       Date:  1966-05       Impact factor: 10.539

View more
  22 in total

1.  Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT).

Authors:  A C Tarn; C von Schnakenburg; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Immunocytochemical localization of peroxisomal proteins in human liver and kidney.

Authors:  M Espeel; G Van Limbergen
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 3.  Molecular therapy of primary hyperoxaluria.

Authors:  Cristina Martin-Higueras; Armando Torres; Eduardo Salido
Journal:  J Inherit Metab Dis       Date:  2017-04-19       Impact factor: 4.982

4.  Primary hyperoxaluria type 1: a cluster of new mutations in exon 7 of the AGXT gene.

Authors:  C von Schnakenburg; G Rumsby
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

5.  Human MiR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis.

Authors:  Xin Tu; Yuanyuan Zhao; Qianqian Li; Xiao Yu; Yang Yang; Shumei Shi; Zuochuan Ding; Yan Miao; Zhimiao Zou; Xinqiang Wang; Jipin Jiang; Dunfeng Du
Journal:  Clin Exp Nephrol       Date:  2019-03-09       Impact factor: 2.801

Review 6.  Molecular and cell biology of primary hyperoxaluria type 1.

Authors:  C J Danpure
Journal:  Clin Investig       Date:  1994-09

7.  Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.

Authors:  C J Danpure; G M Birdsey; G Rumsby; M J Lumb; P E Purdue; J Allsop
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

Review 8.  Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.

Authors:  C J Danpure; P R Jennings; P Fryer; P E Purdue; J Allsop
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.

Authors:  Sonia Fargue; Jackie Lewin; Gill Rumsby; Christopher J Danpure
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

10.  Comparative analysis of an experimental subcellular protein localization assay and in silico prediction methods.

Authors:  Yuhui Hu; Hans Lehrach; Michal Janitz
Journal:  J Mol Histol       Date:  2009-12-22       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.